The authors call for future research to determine whether these findings extend to other populations and health care settings.
Many hospitals and practices across the U.S. have seen a rapid decline in in-person visits since the COVID-19 pandemic.1 Data are limited, however, on how in-person visits to medical facilities may impact a patient’s risk of contracting the virus.
Obstetrical patients are unique in that they required frequent, in-person visits to health care facilities during the pandemic, which is why a team of researchers from Brigham and Women’s Hospital in Boston, MA, set out to investigate whether the number of in-person health care visits were associated with the risk of SARS-CoV-2 infection.2
Published in JAMA Network, the findings suggest that in-person health care visits were not likely to be a major risk factor for SARS-CoV-2 infection and that in-person care can be safely provided when necessary.
“The news here is that there is no news,” says Joshua A. Copel, MD, Professor of Obstetrics, Gynecology, and Reproductive Sciences of Pediatrics at the Yale School of Medicine, and one of Contemporary OB/GYN’’s Editorial Board members.
“The data fail to show an increased risk of COVID-19 associated with in-person prenatal visits, which supports all the efforts we have made to make our offices safe: masks, handwashing, masks, social distancing, and of course, masks,” Dr. Copel says.
The study population included all patients who delivered at 4 hospitals in the Boston area between April 19, 2020, and June 27, 2020, a period when all obstetrical patients were tested for SARS-CoV-2 infection on admission. In total, the study population included 2,968 deliveries; 5 patients were not tested for SARS-CoV-2 infection and were excluded.
The research team matched patients who tested positive for SARS-CoV-2 either during pregnancy or at the time of admission with up to 5 control patients. The controls and cases were matched based on gestational age on the date of positive infection results (±6 days), race/ethnicity, insurance type (Medicaid vs commercial), and SARS-CoV-2 infection rate in the patients’ zip codes.
Using electronic medical record data, the researchers assessed the number of in-person visits for patients from March 10, 2020 (2 weeks prior to the closure of nonessential businesses in Massachusetts) to data about the cases’ SARS-CoV-2 infection diagnoses.
Researchers found that 111 patients (3.7% [95% CI, 3.1%-4.5%]) tested positive for SARS-CoV-2 infection. Of them, 45 tested positive antenatally and 66 tested positive at the time of admission for labor and delivery.
Patients excluded from the study were those residing outside Massachusetts (2.2%), and those whose medical records were missing data required for matching (0.8%). After matching 93 cases with 372 control observations, the mean number of in-person visits was 3.1 (SD, 2.2; range, 0-10) for cases and 3.3 (SD, 2.3; range, 0-16) for controls.
The authors call for future research to determine whether these findings extend to other populations and health care settings.
__
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen